Legal & General Group Plc cut its position in INC Research Holdings, Inc. (NASDAQ:INCR) by 1.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 15,396 shares of the company’s stock after selling 197 shares during the period. Legal & General Group Plc’s holdings in INC Research Holdings were worth $703,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of the company. FMR LLC bought a new position in INC Research Holdings during the fourth quarter worth $13,618,000. Envestnet Asset Management Inc. acquired a new stake in shares of INC Research Holdings during the fourth quarter worth about $109,000. Norges Bank acquired a new stake in shares of INC Research Holdings during the fourth quarter worth about $26,493,000. Teachers Advisors LLC boosted its stake in shares of INC Research Holdings by 5.2% in the fourth quarter. Teachers Advisors LLC now owns 333,908 shares of the company’s stock worth $17,564,000 after buying an additional 16,571 shares in the last quarter. Finally, WCM Investment Management CA boosted its stake in shares of INC Research Holdings by 246.3% in the first quarter. WCM Investment Management CA now owns 30,505 shares of the company’s stock worth $1,399,000 after buying an additional 21,695 shares in the last quarter. 98.70% of the stock is currently owned by institutional investors and hedge funds.
INC Research Holdings, Inc. (INCR) traded down 0.18% during midday trading on Friday, reaching $54.80. 432,327 shares of the company’s stock were exchanged. The company has a market cap of $2.97 billion, a price-to-earnings ratio of 33.58 and a beta of 1.42. INC Research Holdings, Inc. has a 52 week low of $40.65 and a 52 week high of $61.10. The firm has a 50-day moving average price of $56.86 and a 200 day moving average price of $51.93.
INC Research Holdings (NASDAQ:INCR) last released its quarterly earnings data on Thursday, July 27th. The company reported $0.64 earnings per share for the quarter, hitting the consensus estimate of $0.64. The company had revenue of $258.10 million for the quarter, compared to analyst estimates of $256.76 million. INC Research Holdings had a net margin of 5.69% and a return on equity of 40.69%. INC Research Holdings’s revenue for the quarter was down .3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.61 EPS. Analysts anticipate that INC Research Holdings, Inc. will post $2.60 EPS for the current year.
WARNING: This report was first published by Transcript Daily and is owned by of Transcript Daily. If you are reading this report on another site, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this report can be viewed at https://transcriptdaily.com/2017/08/13/legal-general-group-plc-sells-197-shares-of-inc-research-holdings-inc-incr-updated.html.
A number of brokerages recently issued reports on INCR. Goldman Sachs Group, Inc. (The) reiterated a “buy” rating and issued a $65.00 price objective on shares of INC Research Holdings in a report on Monday, August 7th. William Blair cut shares of INC Research Holdings from an “outperform” rating to a “market perform” rating in a report on Tuesday, June 20th. Jefferies Group LLC reiterated a “hold” rating and issued a $62.50 price objective on shares of INC Research Holdings in a report on Sunday, July 30th. SunTrust Banks, Inc. upgraded shares of INC Research Holdings from a “hold” rating to a “buy” rating and upped their price objective for the stock from $48.00 to $67.00 in a report on Wednesday, May 31st. Finally, BidaskClub cut shares of INC Research Holdings from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. One analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $63.79.
In related news, CEO Alistair Macdonald sold 10,555 shares of INC Research Holdings stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $58.38, for a total transaction of $616,200.90. Following the completion of the sale, the chief executive officer now owns 83,935 shares of the company’s stock, valued at approximately $4,900,125.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Christopher L. Gaenzle sold 6,873 shares of INC Research Holdings stock in a transaction dated Friday, June 30th. The stock was sold at an average price of $58.32, for a total transaction of $400,833.36. Following the sale, the chief accounting officer now directly owns 47,450 shares of the company’s stock, valued at approximately $2,767,284. The disclosure for this sale can be found here. 0.24% of the stock is owned by insiders.
About INC Research Holdings
INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.